DoW Autism Clinical Trial Award
DoW Autism Clinical Trial Award is offered by Defense Health Agency Contracting Activity - DHACA. Max award: Not specified. Applications close on Oct 22, 2026.
| Opportunity number | HT942526ARPCTA |
|---|---|
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Posted |
| Posted | May 21, 2026 |
| Closes | Oct 22, 2026 |
| Award ceiling | Not specified |
| Award floor | Not specified |
| Total program funding | $3,250,000 |
| Expected awards | 1 |
| Who can apply | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Category | Science and Technology and other Research and Development |
Summary (excerpt)
Summary: The fiscal year 2026 (FY26) Autism Research Program (ARP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of autism. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from sma…
View the official listing and apply on Grants.gov
Before you apply
- Register your organization in SAM.gov and get a UEI — it can take weeks
- Create a Grants.gov account and check eligibility in the full notice (NOFO)
- Start early; the system gets busy near deadlines
Grants closing soon · More from Defense Health Agency Contracting Activity - DHACA